Cardiovascular Diseases

• FDA approval · 2023-06-05
  FDA Approved: DEFINITY — Supplemental Application (Lantheus Medical Imaging, Inc.)

  FDA approved a supplemental application for DEFINITY (perflutren) submitted by Lantheus Medical Imaging, Inc.

• FDA approval · 2021-09-16
  FDA Approved: OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES — Supplemental Application (GE Healthcare Inc.)

  The FDA approved a supplemental application for GE Healthcare's Optison perflutren protein-type A microspheres (human albumin microspheres a…

• FDA approval · 2016-09-16
  FDA Approved: OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES — Supplemental Application (GE Healthcare Inc.)

  FDA approved a supplemental application for Optison perflutren protein-type A microspheres (human albumin microspheres and perflutren) from …

• FDA approval · 2016-03-31
  FDA Approved: LUMASON — Supplemental Application (BRACCO DIAGNOSTICS INC)

  FDA approves a supplemental application for Lumason (sulfur hexafluoride) from Bracco Diagnostics to expand the approved indications for ult…

• FDA approval · 2015-07-17
  FDA Approved: FLUDEOXYGLUCOSE F18 — Original Application (The Regents of the University of Michigan)

  The FDA approved the Original Application for Fludeoxyglucose F-18, a radiopharmaceutical used for PET imaging. The submission was sponsored…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.